Free tool
Diagnostics stocks
We cover 4 companies grouped under the Diagnostics theme. The median market value in the group is $13.54B. Across the group, the median move over the past trading day is +0.78%. Price change over the past year runs from −27.1% to +122.2% across the middle 80 percent of the group, with a median of +3.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.